Capital Impact Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,299
| Closed | -$499K | – | 97 |
|
|
2024
Q1 | $499K | Sell |
13,299
-10,295
| -44% | -$386K | 0.65% | 68 |
|
|
2023
Q4 | $1.32M | Buy |
23,594
+8,773
| +59% | +$491K | 1.73% | 10 |
|
|
2023
Q3 | $611K | Buy |
14,821
+8,536
| +136% | +$352K | 1.02% | 41 |
|
|
2023
Q2 | $351K | Sell |
6,285
-370
| -6% | -$20.7K | 0.39% | 120 |
|
|
2023
Q1 | $371K | Buy |
6,655
+3,879
| +140% | +$216K | 0.46% | 105 |
|
|
2022
Q4 | $101K | Buy |
2,776
+580
| +26% | +$21.1K | 0.1% | 222 |
|
|
2022
Q3 | $82K | Buy |
+2,196
| New | +$82K | 0.08% | 225 |
|
|
2021
Q4 | – | Sell |
-7,717
| Closed | -$1.12M | – | 149 |
|
|
2021
Q3 | $1.12M | Hold |
7,717
| – | – | 0.45% | 93 |
|
|
2021
Q2 | $1.51M | Buy |
+7,717
| New | +$1.51M | 0.49% | 83 |
|